| Code | Description | Claims | Beneficiaries | Total Paid |
| H0020 |
Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) |
609,559 |
22,319 |
$11.14M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,922 |
6,217 |
$3.26M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,919 |
4,430 |
$1.26M |
| G0378 |
Hospital observation service, per hour |
2,325 |
2,146 |
$1.21M |
| T1007 |
Alcohol and/or substance abuse services, treatment plan development and/or modification |
987 |
972 |
$214K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
597 |
536 |
$194K |
| 90832 |
Psychotherapy, 30 minutes with patient |
2,196 |
1,806 |
$80K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,881 |
3,905 |
$55K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,546 |
873 |
$50K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
957 |
872 |
$46K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,320 |
1,242 |
$32K |
| H2015 |
Comprehensive community support services, per 15 minutes |
262 |
73 |
$19K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,825 |
1,073 |
$13K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
609 |
555 |
$11K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
662 |
336 |
$10K |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
341 |
282 |
$8K |
| 90834 |
Psychotherapy, 45 minutes with patient |
244 |
204 |
$6K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
118 |
103 |
$4K |
| 99215 |
Prolong outpt/office vis |
76 |
66 |
$2K |
| 80305 |
|
1,906 |
1,699 |
$2K |
| J1631 |
Injection, haloperidol decanoate, per 50 mg |
1,601 |
1,230 |
$1K |
| 81025 |
|
93 |
86 |
$787.76 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
30 |
24 |
$696.83 |
| Q3014 |
Telehealth originating site facility fee |
139 |
119 |
$440.31 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
150 |
144 |
$332.49 |
| 84443 |
Thyroid stimulating hormone (TSH) |
56 |
52 |
$317.93 |
| 36415 |
Collection of venous blood by venipuncture |
81 |
78 |
$194.63 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
66 |
56 |
$172.43 |
| 90785 |
|
46 |
27 |
$131.12 |
| 82075 |
|
15 |
13 |
$127.20 |
| 80053 |
Comprehensive metabolic panel |
41 |
38 |
$74.94 |
| 80061 |
Lipid panel |
40 |
40 |
$73.32 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
113 |
85 |
$68.34 |
| J3490 |
Unclassified drugs |
19 |
12 |
$8.72 |